Selected article for: "logistic regression and lymphopenia rate"
Author: Salto-Alejandre, Sonsoles; Jiménez-Jorge, Silvia; Sabé, Nuria; Ramos-Martínez, Antonio; Linares, Laura; Valerio, Maricela; Martín-Dávila, Pilar; Fernández-Ruiz, Mario; Fariñas, María Carmen; Blanes-Juliá, Marino; Vidal, Elisa; Palacios-Baena, Zaira R.; Hernández-Gallego, Román; Carratalá, Jordi; Calderón-Parra, Jorge; Ángeles Marcos, María; Muñoz, Patricia; Fortún-Abete, Jesús; Aguado, José María; Arnaiz-Revillas, Francisco; Blanes-Hernández, Rosa; de la Torre-Cisneros, Julián; López-Cortés, Luis E.; García de Vinuesa-Calvo, Elena; Rosso, Clara M.; Pachón, Jerónimo; Sánchez-Céspedes, Javier; Cordero, Elisa
Title: Risk factors for unfavorable outcome and impact of early post-transplant infection in solid organ recipients with COVID-19: A prospective multicenter cohort study
  • Cord-id: ewgy3jzr
  • Document date: 2021_4_29
    • ID: ewgy3jzr
    Snippet: The aim was to analyze the characteristics and predictors of unfavorable outcomes in solid organ transplant recipients (SOTRs) with COVID-19. We conducted a prospective observational cohort study of 210 consecutive SOTRs hospitalized with COVID-19 in 12 Spanish centers from 21 February to 6 May 2020. Data pertaining to demographics, chronic underlying diseases, transplantation features, clinical, therapeutics, and complications were collected. The primary endpoint was a composite of intensive ca
    Document: The aim was to analyze the characteristics and predictors of unfavorable outcomes in solid organ transplant recipients (SOTRs) with COVID-19. We conducted a prospective observational cohort study of 210 consecutive SOTRs hospitalized with COVID-19 in 12 Spanish centers from 21 February to 6 May 2020. Data pertaining to demographics, chronic underlying diseases, transplantation features, clinical, therapeutics, and complications were collected. The primary endpoint was a composite of intensive care unit (ICU) admission and/or death. Logistic regression analyses were performed to identify the factors associated with these unfavorable outcomes. Males accounted for 148 (70.5%) patients, the median age was 63 years, and 189 (90.0%) patients had pneumonia. Common symptoms were fever, cough, gastrointestinal disturbances, and dyspnea. The most used antiviral or host-targeted therapies included hydroxychloroquine 193/200 (96.5%), lopinavir/ritonavir 91/200 (45.5%), and tocilizumab 49/200 (24.5%). Thirty-seven (17.6%) patients required ICU admission, 12 (5.7%) suffered graft dysfunction, and 45 (21.4%) died. A shorter interval between transplantation and COVID-19 diagnosis had a negative impact on clinical prognosis. Four baseline features were identified as independent predictors of intensive care need or death: advanced age, high respiratory rate, lymphopenia, and elevated level of lactate dehydrogenase. In summary, this study presents comprehensive information on characteristics and complications of COVID-19 in hospitalized SOTRs and provides indicators available upon hospital admission for the identification of SOTRs at risk of critical disease or death, underlining the need for stringent preventative measures in the early post-transplant period.

    Search related documents:
    Co phrase search for related documents
    • adjustment final model and logistic regression: 1
    • adjustment final model and logistic regression analysis: 1
    • admission date and logistic regression: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
    • admission date and logistic regression analysis: 1, 2, 3
    • admission date and lopinavir ritonavir: 1, 2, 3
    • admission rate and logistic regression: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54
    • admission rate and logistic regression analysis: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20
    • admission rate and lopinavir ritonavir: 1, 2, 3, 4, 5, 6, 7, 8, 9
    • admission rate and low inflammatory: 1, 2, 3, 4
    • admission rate and low lymphocyte: 1, 2, 3
    • logistic regression analysis and lopinavir ritonavir: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
    • logistic regression analysis and low lymphocyte: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14
    • logistic regression analysis and lung transplantation: 1, 2, 3
    • logistic regression and lopinavir ritonavir: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29
    • logistic regression and low inflammatory: 1, 2, 3
    • logistic regression and low lymphocyte: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • logistic regression and lung transplantation: 1, 2, 3, 4, 5, 6
    • lopinavir ritonavir and low lymphocyte: 1, 2, 3
    • lopinavir ritonavir and lung transplantation: 1, 2